{"SPADE_UN_15816": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15816", "Peptide Name": "HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "QLGRRRHRRRPSRRRRHW", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/O94992"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MDA-MB-231 (25%Killing=100 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HaCat:Not active up to 100 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C104H180N54O21", "Mass": 2522.89, "PI": 12.0, "Net Charge": 12, "Hydrophobicity": -3.04, "Half Life": "Mammalian:0.8 hourYeast:10 minE.coli:>10 hour", "Literature": [{"Title": "Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy", "Pubmed ID": "26734838", "Reference": "Oncotarget. 2016 Feb 2;7(5)5483-94.", "Author": "Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26734838"}, {"Title": "HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide", "Pubmed ID": "", "Author": "Ho PL, Ong HK, Teo JW, Ow DS, Chao SH"}], "Frequent Amino Acids": "RHG", "Absent Amino Acids": "ACDEFIKMNOTUVY", "Basic Residues": 12, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 14, "Positive Residues": 12, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12935", "Similarity": 1.0, "Sequence": "RQIKIWFQNRRWGGQLGRRRHRRRPSRRRRHW"}, {"SPADE_ID": "SPADE_UN_15820", "Similarity": 1.0, "Sequence": "LTVSPWYGCGQLGRRRHRRRPSRRRRHW"}, {"SPADE_ID": "SPADE_UN_15824", "Similarity": 1.0, "Sequence": "AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW"}]}}}